Austral Capital Partners

Austral Capital Partners is a venture capital firm established in 2008 and based in Santiago, Chile. The firm concentrates on early and growth-stage investments, primarily targeting technology services companies in Chile, Colombia, Peru, and Mexico. Austral Capital seeks to support businesses that have the potential to enhance their growth through expanded service and solution offerings, particularly in the healthcare, financial, retail, and industrial sectors. By investing in companies that provide core digital platforms across these markets, Austral Capital aims to foster innovation and development in the region.

Gonzalo Miranda

Managing Partner

13 past transactions

Fiscalía Privada

Venture Round in 2015
Fiscalía Privada is a legal services platform dedicated to safeguarding companies from criminal activities and managing operational losses. The company offers innovative solutions designed to provide a comprehensive preventive and dissuasive security experience. By enhancing investigative processes and prosecuting those responsible for crimes against corporate assets, such as theft, fraud, and forgery, Fiscalía Privada enables its clients to access legal assistance and seek justice effectively. This approach allows businesses to recover from criminal incidents while facilitating their growth and operational efficiency.

Andes Biotechnologies

Venture Round in 2014
Andes Biotechnologies S.A. is a biotechnology company based in Santiago, Chile, specializing in the research, development, and marketing of innovative anti-cancer drugs and therapies. Founded in 2010, the company focuses on solid tumor cancers and has developed proprietary technologies centered around long non-coding RNAs, specifically sense and antisense RNAs, which are synthesized in mitochondria and migrate to the nucleus. These nucleic acid-based therapeutics are designed to selectively induce apoptosis in cancer cells while sparing normal cells. Andes Biotechnologies is advancing its lead drug, Andes-1537, through clinical development under an active investigational new drug application in the United States. The company benefits from a strong management team, an extensive intellectual property portfolio, and collaborations with key stakeholders in the cancer research community.

Scopix

Series A in 2012
Scopix is a leading provider of intelligent video analytics specifically tailored for retailers, consumer packaged goods (CPG) companies, and manufacturers. The company offers a cloud-based platform that collects and analyzes data, delivering actionable insights through a web-based portal for store personnel, regional managers, and corporate executives. Scopix's Real.Suite family of solutions enables businesses to enhance customer experience by measuring key performance indicators such as staff performance, customer feedback, and queue lengths. These tools are designed to improve retail operations, drive sales, and ultimately maximize profits, ensuring that retailers can adapt quickly to customer needs and market trends.

Scopix

Venture Round in 2012
Scopix is a leading provider of intelligent video analytics specifically tailored for retailers, consumer packaged goods (CPG) companies, and manufacturers. The company offers a cloud-based platform that collects and analyzes data, delivering actionable insights through a web-based portal for store personnel, regional managers, and corporate executives. Scopix's Real.Suite family of solutions enables businesses to enhance customer experience by measuring key performance indicators such as staff performance, customer feedback, and queue lengths. These tools are designed to improve retail operations, drive sales, and ultimately maximize profits, ensuring that retailers can adapt quickly to customer needs and market trends.

Junar

Seed Round in 2012
Junar, Inc. is a provider of a cloud-based open data platform that facilitates the accessibility and management of data for organizations globally. Founded in 2006 and headquartered in Palo Alto, California, with additional offices in Dallas, Silicon Valley, Latin America, and Israel, Junar's platform allows businesses, governments, NGOs, and research institutions to transform complex data into engaging tables, charts, maps, and dashboards. This solution enhances stakeholder engagement, tracks data usage, and measures impact, thereby driving new opportunities and promoting transparency. Furthermore, Junar offers an API toolbox for developers, enabling the creation of innovative applications that showcase data in unique ways. The company is recognized for empowering organizations to leverage their data effectively, contributing to the broader Data Economy.

Nimbic

Venture Round in 2012
Nimbic, headquartered in Mountain View, California, is a provider of cloud-based electronic design automation (EDA) solutions focused on electromagnetic integrity. The company offers advanced software that addresses signal integrity, power integrity, and electromagnetic interference challenges for the microelectronics industry, serving a diverse range of clients, including leading technology firms such as Texas Instruments, Renesas, and Panasonic. Nimbic's nCloud solution supports efficient chip-package-system co-design processes, significantly reducing both time-to-market and costs. With capabilities in 3D electromagnetic analysis, Nimbic’s technology showcases exceptional speed and capacity, enabling comprehensive simulations throughout the design cycle for microprocessors, FPGAs, and other complex systems while delivering accurate results without compromise.

Nimbic

Series B in 2011
Nimbic, headquartered in Mountain View, California, is a provider of cloud-based electronic design automation (EDA) solutions focused on electromagnetic integrity. The company offers advanced software that addresses signal integrity, power integrity, and electromagnetic interference challenges for the microelectronics industry, serving a diverse range of clients, including leading technology firms such as Texas Instruments, Renesas, and Panasonic. Nimbic's nCloud solution supports efficient chip-package-system co-design processes, significantly reducing both time-to-market and costs. With capabilities in 3D electromagnetic analysis, Nimbic’s technology showcases exceptional speed and capacity, enabling comprehensive simulations throughout the design cycle for microprocessors, FPGAs, and other complex systems while delivering accurate results without compromise.

Andes Biotechnologies

Venture Round in 2011
Andes Biotechnologies S.A. is a biotechnology company based in Santiago, Chile, specializing in the research, development, and marketing of innovative anti-cancer drugs and therapies. Founded in 2010, the company focuses on solid tumor cancers and has developed proprietary technologies centered around long non-coding RNAs, specifically sense and antisense RNAs, which are synthesized in mitochondria and migrate to the nucleus. These nucleic acid-based therapeutics are designed to selectively induce apoptosis in cancer cells while sparing normal cells. Andes Biotechnologies is advancing its lead drug, Andes-1537, through clinical development under an active investigational new drug application in the United States. The company benefits from a strong management team, an extensive intellectual property portfolio, and collaborations with key stakeholders in the cancer research community.

Andes Biotechnologies

Series A in 2010
Andes Biotechnologies S.A. is a biotechnology company based in Santiago, Chile, specializing in the research, development, and marketing of innovative anti-cancer drugs and therapies. Founded in 2010, the company focuses on solid tumor cancers and has developed proprietary technologies centered around long non-coding RNAs, specifically sense and antisense RNAs, which are synthesized in mitochondria and migrate to the nucleus. These nucleic acid-based therapeutics are designed to selectively induce apoptosis in cancer cells while sparing normal cells. Andes Biotechnologies is advancing its lead drug, Andes-1537, through clinical development under an active investigational new drug application in the United States. The company benefits from a strong management team, an extensive intellectual property portfolio, and collaborations with key stakeholders in the cancer research community.

Bio Architecture Lab

Series A in 2009
Bio Architecture Lab is a pioneer in the application of synthetic biology and enzyme design to the development of biofuels and renewable chemicals from aquafarmed, native macroalgae (seaweed), which is a low cost, scalable, and sustainable biomass.

Atakama Labs

Seed Round in 2009
Atakama Labs is a developer, publisher, and operator of social games, specializing in creating meaningful gaming experiences. The company focuses on producing games that aim to entertain while also making a positive impact on the world. Their offerings are primarily free to play, ensuring accessibility for a wide audience. Atakama Labs develops its games mainly in Chile and publishes them globally, either directly or through partnerships, depending on the specific platform and region. The company targets popular social platforms, including Facebook, Orkut, iOS, and Android, to reach its players.

Paperless Chile

Series A in 2008
Paperless Chile is a provider of electronic receipts and document management services in Latin America, specializing in the creation, processing, management, and custody of electronic documents. The company processes over two billion documents annually, catering primarily to global enterprise businesses. By offering standardized solutions for electronic invoicing, ballots, and contracts, Paperless enables companies to efficiently store and manage their data in a digital format. This service enhances operational efficiency and contributes to a more sustainable approach to document management.

Scanntech

Venture Round in 2008
Scanntech is a company based in Montevideo, Uruguay, that specializes in providing point-of-sale software and retail analytics solutions for independent supermarkets and fast-moving consumer goods (FMCG) suppliers. Founded in 1992, Scanntech's platform enables retail clients to efficiently process transactions, manage inventory, and access financial services. The software includes features for managing top-ups, ticket waiting functions, and comprehensive reporting, all aimed at enhancing the sales volume and quality for its users. Through its innovative technology, Scanntech supports supermarkets in optimizing their operations and improving customer experiences.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.